Sanara MedTech Inc.

NASDAQ:SMTI

Medical - Instruments & Supplies

Healthcare
$32.73 +3.44%

+$0.73 today

Market cap
$300.55M
Beta
1.19
P/E (TTM)
-5.7
EPS (TTM)
-$3.86
52W Low $16.05High $35.95

Volume 0.07M

Average 0.06M

SMTI Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Sanara MedTech Inc.NASDAQ: SMTI

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q1 FY2026 weighted avg shares (diluted) of 8.99M shares rose 4.9% year over year, ahead of the +3.2% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 4.2% from the prior quarter. Over 3 fiscal years it compounded at +2.9% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +4.9% holds above the trailing-twelve-month pace of +3.2%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
8.99M+4.2% QoQ
Last fiscal yearDec 2025
8.62M+1.6% YoY
LTMMar 2026
8.79M+3.2% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+4.9%——
1 year+1.6%——
3-year CAGR+2.9%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
8.62M USD
Year-over-year change
+1.6%
4-year CAGR
+4.1%

Weighted Avg Shares (Diluted) vs competitors

How SMTI compares with its peers on the latest reported figures

  • SMTI's LTM Mar 2026 weighted avg shares (diluted) of 8.79M shares is the lowest of the 10 companies compared; the peer median is 46.17M shares.
  • Its year-over-year change of +3.2% is the 7th highest of 10, against a peer median of +4.4%.
  • Over three fiscal years its annual growth of +2.9% compares with a peer median of +6.1%.
SMTI Competitors Peer median
Weighted Avg Shares (Diluted) for SMTI and competitors
Company Period LTM YoY 3-year CAGR
NEONeoGenomics, Inc.LTM Jun 2026129.14M +1.5%+1.0%
STXSStereotaxis, Inc.LTM Mar 202693.68M +8.6%+6.1%
HITIHigh Tide Inc.LTM Apr 202687.91M +9.5%+9.4%
SGHTSight Sciences, Inc.LTM Mar 202652.81M +4.4%+2.9%
LFMDLifeMD, Inc.LTM Mar 202646.17M +7.9%+13.4%
TRDAEntrada Therapeutics, Inc.LTM Mar 202641.5M +3.6%+9.8%
VMDViemed Healthcare, Inc.LTM Mar 202640.56M -1.4%+0.8%
XGNExagen Inc.LTM Mar 202622.36M +22.2%+8.1%
TBRGTruBridge, Inc.LTM Mar 202614.51M +1.3%+0.3%
SMTISanara MedTech Inc.LTM Mar 20268.79M +3.2%+2.9%
Peer median (excluding SMTI) 46.17M+4.4%+6.1%

Competitors are the stored peer set for SMTI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue24.14M45.84M64.99M86.67M103.12M
Cost of Revenue2.31M6.36M7.85M8.14M10.18M
Gross Profit21.83M39.48M57.14M78.53M92.94M
Gross Margin90.4%86.1%87.9%90.6%90.1%
Research & Development558.7K3.37M4.13M5.7M5.07M
Selling, General & Admin28.05M45.98M56.99M76.56M78.72M
Operating Expenses29.21M52M61.35M85.25M83.79M
Depreciation & Amortization771.93K2.37M3.68M4.92M2.66M
EBITDA(7.22M)(11.57M)(289.1K)(1.86M)9.03M
EBITDA Margin-29.9%-25.2%-0.4%-2.1%8.8%
Operating Income(7.38M)(12.52M)(4.22M)(6.72M)9.15M
Operating Margin-30.6%-27.3%-6.5%-7.7%8.9%
Interest Income0284.75K021.98K3.67K
Interest Expense711284.75K475.78K3.13M6.76M
Other Income / Expenses(617.64K)(1.42M)(224.75K)(3.2M)(9.54M)
Income Before Tax(7.99M)(13.94M)(4.44M)(9.91M)(393.12K)
Pre-Tax Margin-33.1%-30.4%-6.8%-11.4%-0.4%
Income Tax Expense0(5.84M)000
Net Income(7.92M)(7.94M)(4.3M)(9.66M)(37.56M)
Net Margin-32.8%-17.3%-6.6%-11.2%-36.4%
EPS (Basic)(1.08)(1.00)(0.52)(1.14)(4.36)
EPS (Diluted)(1.08)(1.00)(0.52)(1.14)(4.36)
Weighted Avg Shares7.34M7.91M8.28M8.48M8.62M
Weighted Avg Shares (Diluted)7.34M7.91M8.28M8.48M8.62M

Sanara MedTech Inc.

NASDAQ:SMTI

Intrinsic Alpha fair value

Locked

Current Price

$32.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.